Matthew Perry's Struggles with Ketamine Therapy Detailed in Memoir Before Tragic Death
- Matthew Perry vividly described his experience with ketamine in his memoir.
- The description was published one year before his death from the drug.
- The revelation sheds light on Perry's personal struggles.
In his 2022 memoir, “Friends, Lovers and the Big Terrible Thing,” Matthew Perry candidly shared his experiences with ketamine therapy, which he sought to alleviate his long-standing depression. The beloved “Friends” star described the drug as a euphoric experience, likening it to “being hit in the head with a giant happy shovel.” He recounted the therapy sessions where he would be blindfolded, listen to music, and receive an IV, often leading to disassociative experiences that he found oddly comforting. Perry's reflections revealed a complex relationship with the drug, as he noted feelings of ego dissolution and existential contemplation during the sessions. He expressed a paradoxical attraction to the intense experiences, stating, “I often thought that I was dying during that hour,” yet he continued to seek out the therapy for its novelty. This insight into his psyche painted a picture of a man grappling with deep emotional pain while searching for relief through unconventional means. Tragically, Perry's life came to an end on October 28, 2023, due to the acute effects of ketamine, which led to his drowning. Reports indicate that he was struggling with addiction, despite previously asserting he had maintained sobriety for years. The Department of Justice revealed that Iwamasa, who administered the drug, lacked medical training and had injected Perry multiple times on the day of his death, raising serious concerns about the circumstances surrounding his final moments.